INOTEK PHARMACEUTICALS CORP's ticker is and the CUSIP is 45780VAB8. A total of 10 filers reported holding INOTEK PHARMACEUTICALS CORP in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 7,700,000 | $8,592,000 | 1.03% |
| Bruce & Co., Inc. | 2,000,000 | $2,220,000 | 0.43% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 13,600,000 | $15,130,000 | 0.36% |
| Orbimed Advisors | 7,000,000 | $7,788,000 | 0.09% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,000,000 | $1,108,000 | 0.08% |
| Verition Fund Management LLC | 1,633,000 | $1,826,000 | 0.06% |
| Citadel Advisors | 11,250,000 | $12,462,000 | 0.01% |
| CREDIT SUISSE AG/ | 4,750,000 | $5,239,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |